Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.61 (market cap $127.85B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 10.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.72% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 1 Days on average.
| HALO | MFG | |
|---|---|---|
Market Cap | $12.58B | $127.85B |
Volume | 2,179,278 | 3,950,750 |
Sector | Health | Financials |
52-Week High | $115.22 | $11.45 |
52-Week Low | $61.63 | $6.09 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $35.14T |
Dividend Yield | — | 1.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Mizuho Financial Group Inc. Sponosred ADR (Japan)
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →
